PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors
Rafael Rosell1, Ramón Palmero1
11 Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona 08916, Spain ; 2 Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona 08916, Spain ; 3 Instituto Oncológico Dr Rosell, Quiron Dexeus University Hospital, Barcelona 08028, Spain ; 4 Pangaea Biotech, Barcelona 08028, Spain ; 5 Molecular Oncology Research (MORe) Foundation, Barcelona 08028, Spain ; 6 Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet, Barcelona 08908, Spain.
No abstract available in PubMed .
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
